Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2009
Date:11/6/2009

Revenue for the first nine months of fiscal 2009 was $17.9 million compared with $17.6 million for the first nine months of fiscal 2008. Revenue from product sales in all territories for the first nine months of fiscal 2009 increased to $13.8 million from $9.9 million for the first nine months of fiscal 2008. Revenue from product sales to territories other than the U.S. increased to $11.3 million from $9.9 for the first nine months of fiscal 2008. The increase in products sales to territories other than the U.S. is primarily the result of a higher average selling price per tablet in the first nine months of 2009 due to more favourable country and product dosage strength mixes. Product sales to the U.S. were $2.5 million. Royalty revenue recorded on U.S. sales was $0.3 million.

Gross margin (as a percentage of revenue from product sales) for territories outside the U.S. for the first nine months of fiscal 2009 was 66% compared with 56% for the first nine months of fiscal 2008. Gross margin for territories outside the U.S. for the first nine months of fiscal 2009 includes the reversal of $0.4 million of previously recorded write downs and gross margin for the first nine months of fiscal 2008 includes an inventory write down of $0.4 million. The increase in gross margin was also due to a higher average selling price per tablet in the first nine months of 2009.

Licensing revenue for the first nine months of fiscal 2009 was $3.7 million and represented a portion of licensing payments received from the Company's licensing and distribution partners for once-daily tramadol. Licensing revenue for the first nine months of fiscal 2008 was $7.7 million, including the non-recurring licensing revenue of $4.4 million related to the Company's reacquisition of the rights to its once-daily tramadol product for the United Kingdom.

Net loss for the first nine months of fiscal 2009 was $19.8 million, or $0.35 per share, compared with $26.0 million,
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
2. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
3. Labopharm submits response to FDA for novel antidepressant
4. Labopharm Reports Results for Second Quarter Fiscal 2009
5. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
6. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
7. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
8. Labopharm amends debt facility agreement with Hercules
9. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
10. Labopharm Reports Results for First Quarter Fiscal 2009
11. Labopharm announces details for first quarter results conference call and annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 One in ... according to research presented today at the American Orthopaedic ... The study examined the long term success of surgery ... “We examined survey data from 242 patients who underwent ... Justin P. Roe, MBBS, FRACS, from North Sydney Orthopaedic ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the ... the first time, key information for understanding and treating ... newly posted story on the Surviving Mesothelioma website. ... Columbia, the British Columbia Cancer Agency, and PhenoPath lab ... molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... 28, 2015 Healthpointe’s otolaryngologists, medical practitioners ... throat disorders, are now offering a wide variety ... which is characterized by the presence of phantom sounds ... people, tinnitus is a prevalent symptom that can arise ... is non-fatal, tinnitus can impede a person’s quality of ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 ... of dietary supplements announces the release of their ... was shown in two randomized, double-blind, placebo-controlled clinical ... and waist and hip size. MuffinStop™ is a ... indicus and Garcinia mangostana, fused together to create ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... reproductive success of both men and women is influenced by ... of Sheffield. The study, which was published yesterday (7 ... of Sciences , found that women with higher levels of ... to a larger number of children in societies with traditionally ...
... are immune to a stroke. You may feel healthy; you may ... more vulnerable than you know. That could be because of the ... a result of research from Hopital Notre Dame in Montreal, two ... so silent any more. Lead investigator, neurologist Dr. Alexandre ...
... Researchers from the BC Centre for Excellence in ... released a comprehensive study revealing that the 2008 IAS-USA ... benefits for individuals infected with HIV and society as ... in the research journal PLoS ONE , shows ...
... HACKENSACK, N.J. (June 07, 2010)The John Theurer Cancer Center ... Division of Radiation Oncology has recognized Joseph Hanley, Ph.D., ... his team for outstanding excellence in patient safety. ... exceptional work developing and maintaining Intensity-Modulated Radiation Therapy (IMRT) ...
... very different organisms, they share a surprising number of biological ... one of these mechanisms may be the answer for turning ... of the Molecular Biology and Ecology of Plants Department at ... on cell growth in plants. Now, in a laboratory setting, ...
... most immediate goal for caregivers is to get appropriate ... stop the seizing activity. In a paper published ... emergency medicine assistant professor Jason McMullan, MD, found that ... be with the least direct medication. In the ...
Cached Medicine News:Health News:Research shows personality can predict fertility 2Health News:Under 50? Silent duo could put you at risk for a big stroke 2Health News:Under 50? Silent duo could put you at risk for a big stroke 3Health News:Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs 2Health News:Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs 3Health News:The John Theurer Cancer Center recognizes medical physics team for safety track record 2Health News:A turn-off for cancer 2Health News:Non-IV-administered medication just as effective in stopping seizures 2
(Date:3/27/2015)...  Victoria Vein & Surgery Clinic is the only clinic ... in Victoria, Texas . The clinic specializes ... laser treatments for a variety of medical and cosmetic conditions. ... more services for their patients. Since adding laser tattoo removal, ... residents get rid of their unwanted ink. ...
(Date:3/27/2015)... , March 27, 2015   Cypher ... today announced new data showing that, compared to ... technology provided highly equivalent interpretations of whether ... and did so in a fraction of the ... way for more comprehensive genetic analysis in non-invasive ...
(Date:3/27/2015)... Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in 2015 ... System. ,   ... the NexGen knee system, with its innovative design and component ... the NexGen knee have taken place worldwide. ... importance of design innovation and component quality for surgeons and patients alike," ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2
... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for oral ... Access intends to commercially launch MuGard in North America ... pertaining to the launch include: , Manufacturing : ...
... Nov. 11 Pharma market research thought leaders are discovering ... opportunities in the pharmaceutical industry. The last twelve months ... Pharmaceutical market research is no exception. But those ... information today will certainly rise to be the new leaders ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 4Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... is a minimally invasive, highly effective surgical ... incontinence. GYNECARE TVT is positioned close to ... and when needed, TVT provides tension-free support ... The procedure takes approximately 20 to 30 ...
...
...
Medicine Products: